文献速递免疫规划妇幼与学校卫生

接种水痘疫苗与自然感染女性长期T细胞免疫不同但抗体水平相似

Women who received varicella vaccine versus natural infection have different long-term T cell immunity but similar antibody levels.
PubMed 文献 · Vaccine · 2020-01-17

研究招募18至36岁有VZV免疫史(n=20)或曾患水痘(n=20)的非妊娠女性,比较抗体滴度与T细胞反应。两组中位抗体滴度无显著差异(p=0.34),但水痘组VZV抗原特异性CD4 T细胞水平显著更高(p=0.004)。结论:自然感染诱导的VZV特异性T细胞免疫反应高于疫苗接种。

要点

  • 接种疫苗组与曾患水痘组中位抗体滴度无显著差异(p=0.34)。
  • 水痘组VZV抗原特异性CD4 T细胞水平显著高于接种组(p=0.004)。
  • 自然感染诱导的VZV特异性T细胞免疫反应高于疫苗接种。

核心结论

  • 自然感染诱导的VZV特异性T细胞免疫反应高于疫苗接种。

研究设计与样本

  • 招募18至36岁有VZV免疫史(n=20)或曾患水痘(n=20)的非妊娠女性。
  • 采用流式细胞术方法分别检测血清IgG抗体滴度和外周血T细胞反应。

主要发现

  • 接种组与曾患水痘组中位抗体滴度无显著差异(p=0.34)。
  • 水痘组VZV抗原特异性CD4 T细胞水平显著高于接种组(p=0.004)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Varicella-zoster virus (VZV) infection during pregnancy is associated with serious fetal anomalies. The live-attenuated VZV vaccine was approved in 1995, so many vaccinated women are now of childbearing age. The question of long-term immunity to varicella is critical because breakthrough chickenpox can occur after vaccination. OBJECTIVE: To compare humoral and T cell immunity between women of childbearing age who were immunized by vaccination or chickenpox disease. STUDY DESIGN: Non-pregnant females between 18 and 36 years old with a history of VZV immunization (n = 20) or prior chickenpox disease (n = 20) were recruited. IgG antibody titers and T cell responses were measured by flow cytometry-based methods in serum and peripheral blood, respectively. RESULTS: There were no significant differences in median antibody titers between vaccinated and chickenpox groups (p = 0.34). The chickenpox group had significantly higher levels of VZV antigen-specific CD4 T cells (p = 0.004). CONCLUSION: Natural infection induced higher VZV-specific T cell immune responses than vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Tourtelot E, Quataert S, Glantz JC, et al. Women who received varicella vaccine versus natural infection have different long-term T cell immunity but similar antibody levels. Vaccine. 2020. PMID: 31959424. doi:10.1016/j.vaccine.2019.12.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。